Neuromedin U and neurotensin may promote the development of the tumour microenvironment in neuroblastoma

Stage 4S neuroblastoma, as defined by the International Neuroblastoma Staging System committee (INSS), is known to regress spontaneously and have a more favourable outcome compared with stage 4 tumours. Comparing the molecular differences between these two stages may provide insights into the progre...

Full description

Bibliographic Details
Main Authors: Daheng Yang, Xianwei Zhang, Zheqian Li, Fei Xu, Chenjie Tang, Hongbing Chen
Format: Article
Language:English
Published: PeerJ Inc. 2021-06-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/11512.pdf
_version_ 1797419712656703488
author Daheng Yang
Xianwei Zhang
Zheqian Li
Fei Xu
Chenjie Tang
Hongbing Chen
author_facet Daheng Yang
Xianwei Zhang
Zheqian Li
Fei Xu
Chenjie Tang
Hongbing Chen
author_sort Daheng Yang
collection DOAJ
description Stage 4S neuroblastoma, as defined by the International Neuroblastoma Staging System committee (INSS), is known to regress spontaneously and have a more favourable outcome compared with stage 4 tumours. Comparing the molecular differences between these two stages may provide insights into the progression of neuroblastoma. Our study aimed to explore the molecular differences in the tumour microenvironment (TME) between INSS stage 4S and stage 4 tumours to provide an insight into the mechanisms underlying the biological processes of neuroblastoma. We downloaded the datasets GSE120572 and GSE73517 from the GEO database and pre-processed them using the limma package. CIBERSORT deconvolution agorithm was applied to analyse the differences in 22 infiltrating immune leukocyte subsets between the two stages. We used gene ontology (GO) enrichment analysis to determine the biological process (BP) annotation of differentially expressed genes (DEGs) using the online WebGestalt tool. Hub genes were determined in the STRING database and Cytoscape, and the expression of these genes was verified in the Oncomine database. Then these critical genes were performed survival analysis in TARGET database. We further validated the hub genes using a transwell assay and wound healing assay to detect the function of the genes in the neuroblastoma cell line SK-N-BE(2). GO analysis revealed that the 216 DEGs between stage 4S and stage 4 were enriched in aggressive biological processes. Neuromedin U (NMU) and neurotensin (NTS), which were significantly associated with patients’ overall survival rate, were verified to be elevated in stage 4, and to promote the proliferation and invasion of the SK-N-BE(2) cell. Tumour infiltrating leukocyte analysis showed a high infiltration of regulatory T cells and type 2 tumour-associated macrophages in stage 4 but not in stage 4S. Results of gene co-expression correlation, and the results of previous studies, suggest that NMU and NTS may play certain roles in modulating TME, thus facilitating the progression of neuroblastoma.
first_indexed 2024-03-09T06:51:19Z
format Article
id doaj.art-8e8d2e705f6c47d0a3746b6ad2a45095
institution Directory Open Access Journal
issn 2167-8359
language English
last_indexed 2024-03-09T06:51:19Z
publishDate 2021-06-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj.art-8e8d2e705f6c47d0a3746b6ad2a450952023-12-03T10:26:22ZengPeerJ Inc.PeerJ2167-83592021-06-019e1151210.7717/peerj.11512Neuromedin U and neurotensin may promote the development of the tumour microenvironment in neuroblastomaDaheng Yang0Xianwei Zhang1Zheqian Li2Fei Xu3Chenjie Tang4Hongbing Chen5Department of Clinical Laboratory, Children’s Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Clinical Laboratory, Children’s Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Clinical Laboratory, Children’s Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Clinical Laboratory, Children’s Hospital of Nanjing Medical University, Nanjing, ChinaWuxi Children’s Hospital, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, ChinaDepartment of Clinical Laboratory, Children’s Hospital of Nanjing Medical University, Nanjing, ChinaStage 4S neuroblastoma, as defined by the International Neuroblastoma Staging System committee (INSS), is known to regress spontaneously and have a more favourable outcome compared with stage 4 tumours. Comparing the molecular differences between these two stages may provide insights into the progression of neuroblastoma. Our study aimed to explore the molecular differences in the tumour microenvironment (TME) between INSS stage 4S and stage 4 tumours to provide an insight into the mechanisms underlying the biological processes of neuroblastoma. We downloaded the datasets GSE120572 and GSE73517 from the GEO database and pre-processed them using the limma package. CIBERSORT deconvolution agorithm was applied to analyse the differences in 22 infiltrating immune leukocyte subsets between the two stages. We used gene ontology (GO) enrichment analysis to determine the biological process (BP) annotation of differentially expressed genes (DEGs) using the online WebGestalt tool. Hub genes were determined in the STRING database and Cytoscape, and the expression of these genes was verified in the Oncomine database. Then these critical genes were performed survival analysis in TARGET database. We further validated the hub genes using a transwell assay and wound healing assay to detect the function of the genes in the neuroblastoma cell line SK-N-BE(2). GO analysis revealed that the 216 DEGs between stage 4S and stage 4 were enriched in aggressive biological processes. Neuromedin U (NMU) and neurotensin (NTS), which were significantly associated with patients’ overall survival rate, were verified to be elevated in stage 4, and to promote the proliferation and invasion of the SK-N-BE(2) cell. Tumour infiltrating leukocyte analysis showed a high infiltration of regulatory T cells and type 2 tumour-associated macrophages in stage 4 but not in stage 4S. Results of gene co-expression correlation, and the results of previous studies, suggest that NMU and NTS may play certain roles in modulating TME, thus facilitating the progression of neuroblastoma.https://peerj.com/articles/11512.pdfNeuroblastomaTumour microenvironmentNeuromedin UNeurotensinINSS stage
spellingShingle Daheng Yang
Xianwei Zhang
Zheqian Li
Fei Xu
Chenjie Tang
Hongbing Chen
Neuromedin U and neurotensin may promote the development of the tumour microenvironment in neuroblastoma
PeerJ
Neuroblastoma
Tumour microenvironment
Neuromedin U
Neurotensin
INSS stage
title Neuromedin U and neurotensin may promote the development of the tumour microenvironment in neuroblastoma
title_full Neuromedin U and neurotensin may promote the development of the tumour microenvironment in neuroblastoma
title_fullStr Neuromedin U and neurotensin may promote the development of the tumour microenvironment in neuroblastoma
title_full_unstemmed Neuromedin U and neurotensin may promote the development of the tumour microenvironment in neuroblastoma
title_short Neuromedin U and neurotensin may promote the development of the tumour microenvironment in neuroblastoma
title_sort neuromedin u and neurotensin may promote the development of the tumour microenvironment in neuroblastoma
topic Neuroblastoma
Tumour microenvironment
Neuromedin U
Neurotensin
INSS stage
url https://peerj.com/articles/11512.pdf
work_keys_str_mv AT dahengyang neuromedinuandneurotensinmaypromotethedevelopmentofthetumourmicroenvironmentinneuroblastoma
AT xianweizhang neuromedinuandneurotensinmaypromotethedevelopmentofthetumourmicroenvironmentinneuroblastoma
AT zheqianli neuromedinuandneurotensinmaypromotethedevelopmentofthetumourmicroenvironmentinneuroblastoma
AT feixu neuromedinuandneurotensinmaypromotethedevelopmentofthetumourmicroenvironmentinneuroblastoma
AT chenjietang neuromedinuandneurotensinmaypromotethedevelopmentofthetumourmicroenvironmentinneuroblastoma
AT hongbingchen neuromedinuandneurotensinmaypromotethedevelopmentofthetumourmicroenvironmentinneuroblastoma